Why a Smartwatch Sleep Apnea Feature Needs a CE Mark Before It Switches On in Europe

The smartwatch sleep apnea feature Europe CE mark is a medical certificate, not a software toggle

Your apnoea detection is greyed out because the smartwatch sleep apnea feature Europe CE mark is a medical-device certification, not a setting. Under Regulation (EU) 2017/745, the EU MDR, an algorithm that flags possible obstructive sleep apnoea (OSA) counts as a medical device in its own right. A notified body has to assess it before it can legally run in the European Economic Area. Until a certificate covers your market, the feature stays dark. No update unlocks it.

This is a legal problem, not a hardware one. The sensors already work, and how well they work is a separate argument we unpack in our look at how accurate Apple Watch sleep apnea detection really is. What is missing in an uncertified market is permission, not capability.

Samsung Electronics announced in 2025 that its Galaxy Watch feature had reached 34 European markets and 70 markets globally after securing CE marking for the EEA. The European Commission notified body survey, reference date 28 February 2025, counted 28,489 MDR applications against 12,177 certificates issued across 51 notified bodies.

What most smartwatch apnoea guides get wrong about Europe

Two errors repeat across nearly every page that ranks for this question. Both leave European readers stuck.

Flaw one, treating the EU like a single approving agency

There is no European FDA. Nothing is waiting on EU approval, because no EU body approves consumer devices one by one. The manufacturer draws up an EU Declaration of Conformity and carries the legal responsibility for it. A private, government-designated notified body, organisme notifié in French and Benannte Stelle in German, performs the conformity assessment and issues the certificate. These are commercial organisations with four-digit identifiers. One French-built ECG smartwatch, for example, was certified by notified body 1282, Ente Certificazione Macchine, under the older Medical Device Directive that the MDR replaced on 26 May 2021.

Flaw two, assuming the flag already happened

Most explainers open with your watch flagged you, here is what to do next. That decision tree is useless to a reader whose feature never turned on. Worse, it is built around a care pathway that does not describe how access to testing works in France, Germany, Italy or Spain, where a prescription usually controls both the test and its cost.

Rule 11 turns a sleep app into a Class IIa device

MDR Annex VIII Rule 11 is the actual switch. Software that provides information used to take decisions with a diagnostic purpose is Class IIa by default. An app built to detect sleep apnoea is a textbook worked example: Class I under the old directive, Class IIa or higher under the MDR. Class I products can be self-certified. Class IIa cannot, which is exactly why a notified body now stands between the algorithm and the European wrist.

Whether the software is regulated at all turns on the claimed intended purpose, not on the sensor. MDCG 2019-11, the EU guidance on qualification and classification of medical device software, was revised in June 2025 and still hinges on what the maker claims. The MDR explicitly excludes software intended for lifestyle and well-being purposes. Identical photoplethysmography and accelerometer data can therefore be an uncertified sleep score or a Class IIa apnoea detector, depending purely on the wording of that claim.

That table explains a puzzle many readers notice. Rings and fitness straps report nightly breathing disturbances across the whole EEA without any medical certification, while the two features that name sleep apnoea directly had to wait. The wording is the regulatory event. A related annexe, MDR Annex XVI, does the same job in reverse for products with no medical purpose that still carry device-level risk.

The two CE marks on your box are not the same mark

Every smartwatch sold in the EEA already carries a CE mark. It covers the Radio Equipment Directive, electromagnetic compatibility and low-voltage safety. It says nothing about health claims. A medical-device CE mark for a Class IIa feature looks different in one specific way: it is accompanied by the four-digit number of the notified body that assessed it. No number, no medical certification.

The practical consequence is simple. A CE symbol on your packaging tells you the radio module is compliant. It does not tell you that anyone ever assessed an apnoea algorithm.

Why the smartwatch sleep apnea feature Europe CE mark trails a US clearance

The lag is a queue, not corporate reluctance. The American Academy of Sleep Medicine reported the Samsung US authorisation in February 2024, and Samsung announced CE marking for the EEA in June 2025, more than a year later. The Apple sleep apnea notification received US clearance on 13 September 2024 (AASM, 2024). Behind those dates sits the European Commission survey figure: 28,489 MDR applications against 12,177 certificates, with 60% of submissions taking 13 to 18 months and 92% taking over 13 months (European Commission, 2025).

A second layer arrives on 2 August 2027. Under the EU AI Act, Regulation (EU) 2024/1689, an AI system embedded in a product covered by the MDR that requires third-party conformity assessment automatically counts as a high-risk AI system. Every Class IIa apnoea algorithm using AI inherits those obligations, assessed in a single integrated procedure by a notified body designated under both regimes. That is more assessment work landing on an already loaded queue, not less.

Still greyed out after the update, so check where you bought it

Certification alone does not turn the feature on for you. The service is bound to the market where the watch and the paired phone were purchased, not where you live. The Samsung software-as-a-medical-device notice states the feature only works on watches and smartphones purchased in markets where the service is available, and that service may be restricted when users travel into non-service markets. Inside a single market built on free movement of goods, a grey-imported or foreign-bought watch can stay dark permanently for an EU resident.

Type sleep apnea feature not available in my country into a search box and you get American answers to a European legal problem. If you are still choosing hardware, our comparison of Galaxy Watch and Apple Watch apnoea screening covers what each device actually measures. Geography is messier than the marketing suggests, too. The Samsung list of 34 markets mixes three legal regimes without distinguishing them.

Verify the certificate yourself in EUDAMED

Since 28 May 2026 you no longer have to take anyone at their word. Commission Decision (EU) 2025/2371 made the first four EUDAMED modules mandatory: Actor registration, UDI/Devices registration, Notified Bodies and Certificates, and Market Surveillance (European Commission, DG SANTE, 2026). Whether a smartwatch sleep apnea feature Europe CE mark covers your market became a public lookup rather than a marketing claim.

1. Find the Basic UDI-DI for the device or software, normally in the regulatory or legal information screen.
2. Open the public EUDAMED site and search the UDI/Devices module for that identifier.
3. Open the Notified Bodies and Certificates module and confirm a live certificate and its four-digit body.
4. Read the registered intended purpose and compare it with what the app screen promises.
5. If nothing appears, treat the metric as wellness software in your market, not a certified detector.

Our step-by-step on checking an anti-snoring device in the EUDAMED database walks through the same search screens for physical devices.

What a watch flag is worth inside your national pathway

A notification is a screening signal, never a diagnosis. It matters because the underlying condition is common and widely missed. In the Swiss HypnoLaus cohort (Heinzer et al., The Lancet Respiratory Medicine, 2015; n=2,121, median age 57), 49.7% of men and 23.4% of women aged 40 and over had an apnoea-hypopnoea index of 15 or more events per hour. Hypopnoea was the most frequent event at 75%, followed by obstructive apnoea at 19%. Globally, Benjafield et al. (The Lancet Respiratory Medicine, 2019) estimated 936 million adults aged 30 to 69 live with mild to severe obstructive sleep apnoea.

Accuracy varies sharply by device and by threshold. Read the specificity column carefully. A flag means something, while the absence of a flag means very little.

That same 2025 independent study found systematic underestimation of true AHI against polysomnography, most pronounced in mild cases (mean difference -2.93). Europe is funding its own answer to this question through the Sleep Revolution project (Horizon 2020 grant 965417, coordinated by Reykjavik University, 2021-2025), which ran multicentre trials across 39 partner institutions to validate consumer sleep technology against clinical standards.

Then there is reimbursement, which no wearable unlocks. In France the first-line reimbursed examination is a polygraphie ventilatoire, prescribed inside the parcours de soins, with a Sécurité sociale base de remboursement of 119 € (145 € under the Optam tariff option) reimbursed at 70% of that base. A watch notification unlocks none of that. The prescription does.

A four-step protocol you can start tonight

You cannot speed up a notified body queue. You can settle the smartwatch sleep apnea feature Europe CE mark question for your own device this evening, and get a real answer about your breathing while you wait.

If testing confirms simple snoring or mild-to-moderate obstructive sleep apnoea, a clinician can discuss the options that suit that severity, including a mandibular advancement device, positional therapy, or a soft silicone nasal stent that holds the nasal airway open during sleep. Severe disease is a different conversation, where continuous positive airway pressure (CPAP, or PPC in France) remains the reference treatment. None of these choices replaces the test that names the problem.

Frequently Asked Questions